our goal

Making Surgical Risk Predictable.

Safer Surgery With Better Outcomes For Patients, Providers And Purchasers.

Safer outpatient surgery with better outcomes for patients, providers and purchasers.

“The ongoing transformation of surgical care from the inpatient to outpatient setting imparts an unprecedented level of risk to the surgeon and provider facility.”

Chief Executive Officer, Soteria Medical Risk

Soteria uses proprietary data analytics to overhaul how surgical risk is assessed, managed, and mitigated.

The ability to assess the specific risk of a surgeon or facility is limited leading to generic and unfocused risk assessment and mitigation programs. This generic approach is expensive, time consuming, and only marginally effective. In contrast, Soteria predicts the risk of a specific surgeon or facility leading to customized risk management and mitigation solutions for our customers. Making surgical risk predictable leads to safer surgery with better outcomes for patients, providers, and purchasers.

Research indicates more than 60 percent of surgical procedures can be performed same day in a hospital outpatient department (HOPD) or Ambulatory Surgery Center (ASC). That number will continue to rise with technology advancements and pressure to reduce the cost of healthcare to the federal government, commercial payers, and consumers. And while the long-term impact of COVID-19 on consumer attitudes is unknown, early research suggests an increased preference for elective surgeries to be performed outside of hospitals.

With more complicated surgical procedures moving to the outpatient environment, most likely into relatively unregulated ASCs, proactively identifying and eliminating risk is more important than ever for patients. Since Soteria’s patent pending Surgical Risk Assessment Program (SRAP) predicts risk at the surgeon and facility levels, customized interventions are now possible.

Dr. Meneghini’s Bio

R. Michael Meneghini, MD

BOARD-CERTIFIED ORTHOPAEDIC SURGEON

Dr. Meneghini is a board-certified, fellowship-trained orthopaedic surgeon and leading national expert in total hip and knee replacement. Dr. Meneghini received his undergraduate degree in engineering from Rose-Hulman Institute of Technology, before attending Indiana University School of Medicine.  He completed his orthopaedic residency at Rush University Medical Center in Chicago followed by a fellowship in Adult Hip and Knee Reconstruction at the Mayo Clinic.  Dr. Meneghini is the recipient of numerous awards including the Indiana University School of Medicine Early Career Achievement Award and the Rose-Hulman Institute of Technology Career Achievement Award.  He is also a member of the prestigious Hip and Knee Societies.

 Dr. Meneghini has a special interest in clinical research, with a particular expertise in outpatient surgical risk assessment and stratification and is the author of over 125 scientific articles on hip and knee replacement.  Dr. Meneghini holds numerous patents and is the co-inventor and developer of the Outpatient Arthroplasty Risk Assessment (OARATM) Score, a commercially available medical risk assessment tool for outpatient surgery.”

About

R. Michael Meneghini, MD

BOARD-CERTIFIED ORTHOPAEDIC SURGEON

meet

Our Team

Michael Meneghini, MD

Founder

Julie Carmichael, MBA, FACHE

Senior Advisor

Jennifer Fry,
CPA

Senior Advisor

Advisory Board

Sean Mullins, MHA

Chief Operating Officer, Olio

Marshall Maran

CEO, American Orthopedic Partners

Albert “Barclay” Wong

Partner, Drewry Simmons Vornehm, LLP
Soteria Medical Risk

How it Works

STEP 1

TITLE

SUB TEXT
OTHER INFO​

STEP 2

TITLE

SUB TEXT
OTHER INFO​

STEP 3

TITLE

SUB TEXT
OTHER INFO​
Do you have any questions?

Contact Us

Scroll to Top